MeSH tree: D03.383.129.308.240
When doctors biopsy and treat cancer may be just as important as how they treat it. New research from Erik Herzog, Ph.D., the Viktor Hamburger Distinguished Professor in biology in Arts & Sciences at Washington University ...
Nov 20, 2025
0
14
Results of a study led by researchers at Roswell Park Comprehensive Cancer Center are shedding light on why some newly diagnosed glioblastoma patients survive longer than others after receiving standard treatment in conjunction ...
Oct 16, 2025
0
21
Previously, results from the photon cohort of the NRG-BN001, a signal seeking Phase II randomized trial, indicated that photon radiation dose intensification (75 Gy) did not demonstrate improvement in overall survival (OS) ...
Oct 1, 2025
0
14
Research has revealed a new mechanism within cancer cells that could be exploited to treat glioblastoma—one of the deadliest types of brain tumors.
Sep 2, 2025
0
29
NRG Oncology recently reported the results of the phase II/III NRG-BN007 clinical trial showing that combining ipilimumab and nivolumab with radiation therapy (RT) did not improve progression-free survival (PFS) for patients ...
Aug 13, 2025
0
22
A group led by the Department of Neurosurgery at the Brain Research Institute, Niigata University, has successfully treated a patient with a brainstem glioma harboring a rare IDH2 mutation. The case report was published online ...
Jul 17, 2025
0
11
In a clinical practice guideline issued by the American Society for Radiation Oncology and published online June 25 in Practical Radiation Oncology, updated recommendations are presented for the management of World Health ...
Jul 8, 2025
0
14
A new study led by Keck Medicine of USC researchers may have uncovered an effective combination therapy for glioblastoma, a brain tumor diagnosis with few available effective treatments. According to the National Brain Tumor ...
Jun 9, 2025
0
39
A lab-designed molecule developed and extensively studied by scientists with Virginia Tech's Fralin Biomedical Research Institute at VTC could represent a breakthrough in slowing tumor recurrence in glioblastoma, an aggressive ...
May 29, 2025
0
24
Scientists at the Terasaki Institute for Biomedical Innovation (TIBI), led by Dr. Vadim Jucaud (Assistant Professor), have engineered a novel multi-cellular 3D glioblastoma (GBM) in vitro model that mimics the biomechanical ...
May 27, 2025
0
10
